Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy

被引：0

作者：

Cannie, D. ^{[1
,2
]}

Bakalakos, A. ^{[1
,2
]}

Protonotarios, A. ^{[1
,2
]}

Syrris, P. ^{[1
]}

Lorenzini, M. ^{[1
,2
]}

Guttmann, O. ^{[1
,2
]}

O'mahony, C. ^{[1
,2
]}

Savvatis, K. ^{[1
,2
]}

Lopes, L. ^{[1
,2
]}

Sekhri, N. ^{[2
]}

Mohiddin, S. ^{[2
]}

Elliott, P. ^{[1
,2
]}

机构：

[1] UCL, London, England

[2] Barts Heart Ctr, London, England

来源：

EUROPEAN HEART JOURNAL | 2023年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[21] Tranilast, Orally Active TRPV2 Antagonist, Ameliorates End-stage Heart Failure in Mice with Dilated Cardiomyopathy [J].

Komamura, Kazuo ;

Iwata, Yuko .

JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) :S198-S199

[22] Myocardial capillary density is severely reduced in patients with end-stage congestive heart failure secondary to idiopathic dilated cardiomyopathy [J].

Tsagalou, E. ;

Agapitos, E. ;

Kanakakis, J. ;

Alexopoulos, G. ;

Ntalianis, A. ;

Lazaris, N. ;

Pantsios, C. ;

Nanas, J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :A308-A308

[23] Tranilast, Transient Receptor Potential Vanilloid 2 Antagonist, Ameliorates End-Stage Heart Failure of Mice With Dilated Cardiomyopathy [J].

Iwata, Yuko ;

Komamura, Kazuo .

CIRCULATION, 2014, 130

[24] Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy [J].

Sushma Reddy ;

Alan Fung ;

Cedric Manlhiot ;

Elif Seda Selamet Tierney ;

Wendy K. Chung ;

Elizabeth Blume ;

Beth D. Kaufman ;

Elizabeth Goldmuntz ;

Steven Colan ;

Seema Mital .

Pediatric Research, 2015, 77 :363-369

[25] Improved early outcome for end-stage dilated cardiomyopathy in children [J].

McMahon, AM ;

van Doorn, C ;

Burch, M ;

Whitmore, P ;

Neligan, S ;

Rees, P ;

Radley-Smith, R ;

Goldman, A ;

Brown, K ;

Cohen, G ;

Tsang, V ;

Elliott, M .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (06) :1781-1787

[26] Partial left ventriculectomy in pediatric end-stage dilated cardiomyopathy [J].

Shinpei Yoshii ;

Shoji Suzuki ;

Shigeru Hosaka ;

Hiroshi Osawa ;

Wataru Takahashi ;

Samuel JK Abraham ;

Yusuke Tada ;

Hisashi Sugiyama ;

Tetsushi Tan ;

Hiroshi Kanazawa .

The Japanese Journal of Thoracic and Cardiovascular Surgery, 2002, 50 (6) :235-240

[27] Partial left ventriculectomy for the treatment of end-stage dilated cardiomyopathy [J].

Huang, FJ ;

Zhang, JQ ;

Yang, JF ;

Bo, P ;

You, B ;

Cao, XR ;

Han, J ;

Huang, GH ;

Xu, CL ;

Wu, Q ;

Chen, YC .

CHINESE MEDICAL JOURNAL, 1999, 112 (11) :1001-1004

[28] Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy [J].

de Leeuw, N ;

Melchers, WJG ;

Balk, AHMM ;

de Jonge, N ;

Galama, JMD .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :522-525

[29] ICDs in end-stage heart failure [J].

Pettit, Stephen J. ;

Browne, Susan ;

Hogg, Karen J. ;

Connelly, Derek T. ;

Gardner, Roy S. ;

May, Carl R. ;

Macleod, Una ;

Mair, Frances S. .

BMJ SUPPORTIVE & PALLIATIVE CARE, 2012, 2 (02) :94-97

[30] Levosimendan in End-Stage Heart Failure [J].

Yeo, Poh Shuan Daniel .

JACC-HEART FAILURE, 2013, 1 (04) :365-365

← 1 2 3 4 5 →